Newsletter “Segnali di fumo” → Join now
Tribe Events

Startup

PANOXYVIR

The main area of intervention for Panoxyvir is that of viral respiratory infections. A formulation is being developed containing a cholesterol metabolite as an active ingredient, to be administered by spray for the treatment and prevention of rhinovirus and coronavirus infections. This formulation was also effective against a clinical isolate of SARS-CoV-2, thanks to the demonstrated broad-spectrum antiviral activity of the investigational molecule.
Last update: 28/02/2021

Contacts

Turin

http://www.panoxyvir.com
info@panoxyvir.com

-

Team

Co-founder & CEO: Giuseppe Poli
Co-founder & CSO: David Lembo
Co-founder & CTO: Andrea Civra

Details

Year of establishment: 2016

Incubation/acceleration programme: Bioindustry Park Silvano Fumero

Awards:

    2016 - 1st Bioupper Prize 1st edition: € 50,000, 2016 - 1st Start Cup Prize, Piedmont and Valle d'Aosta: € 10,000, 2016 - 1st overall and 1st category Life Science, National Innovation Award (PNI) : € 25,000, 2017 - Prize of Prizes, awarded by the President of the Chamber of Deputies and the Cotec Foundation., 2018 - Corporate Fast Track Prize, as part of the Marzotto Prize (among the five finalists). Acceleration path worth € 50,000, 2018 - Leonardo Startup Award, assigned by the Leonardo Committee - Leonardo Italian Quality Committee, the Italian Ministry for Economic Development and the ICE Agency.

Sectors: Pharmaceutical & Biotech

More profiles in Startup

Startup

Enermove

Startup

GeDy TrAss

Startup

ARISK

Startup

HYPE

Are you part of PANOXYVIR?
Report any changes to us at info@torinotechmap.it

Back to Ecosystem

List your organization in Torino Tech Map

I would like to list my business on ToTeM

If you have an innovative startup that was born or is operating in the Turin area, become part of our ecosystem mapping. You can fill in the form even if you are not yet established or if your product is not yet on the market.

Fill in the form